COLLATERAL AGREEMENT DATED AS OF DECEMBER 22, 2015 AMONG MERRIMACK PHARMACEUTICALS, INC., as Issuer, THE SUBSIDIARY PARTIES FROM TIME TO TIME PARTY HERETO as Trustee, and as Collateral AgentCollateral Agreement • December 22nd, 2015 • Merrimack Pharmaceuticals Inc • Pharmaceutical preparations • New York
THIS COLLATERAL AGREEMENT (as amended, extended, renewed, restated, supplemented, waived or otherwise modified from time to time, this “Agreement”) is entered into as of December 22, 2015, by and among MERRIMACK PHARMACEUTICALS, INC., a Delaware corporation with an address at One Kendall Square, Suite B7201, Cambridge, Massachusetts 02139, (the “Issuer”), the SUBSIDIARY PARTIES (as defined below) from time to time party hereto, U.S. BANK NATIONAL ASSOCIATION, in its capacity as Trustee (and its successors under the Indenture (as defined below), in such capacity, the “Trustee”), and U.S. BANK NATIONAL ASSOCIATION, in its capacity as collateral agent for the Secured Parties (as defined below) (and its successors under the Indenture, in such capacity, the “Collateral Agent”).
MERRIMACK PHARMACEUTICALS, INC., as Issuer, and any Guarantor that becomes party hereto pursuant to Section 4.10 hereof 11.5% Senior Secured Notes due 2022 INDENTURE Dated as of December 22, 2015 U.S. BANK NATIONAL ASSOCIATION, as Trustee and as...Indenture • December 22nd, 2015 • Merrimack Pharmaceuticals Inc • Pharmaceutical preparations • New York
INDENTURE dated as of December 22, 2015 among Merrimack Pharmaceuticals, Inc., a Delaware corporation with an address at One Kendall Square, Suite B7201, Cambridge, Massachusetts 02139 (the “Issuer”), any Guarantor that becomes party hereto pursuant to Section 4.10, and U.S. Bank National Association, as trustee (as more fully defined in Section 1.01, the “Trustee”) and as collateral agent (as more fully defined in Section 1.01, the “Collateral Agent”).
